Nigella Sativa Oil for Oral Mucositis

Oral mucositis (OM) is common treatment-induced toxicity in patients receiving chemoradiation for head and neck cancer (HNC). The present study aims to evaluate the efficacy and safety of Nigella sativa (NS) oil in chemoradiation-induced OM of HNC patients. From   January 2017 to May 2018, 40...

Full description

Bibliographic Details
Main Authors: Hazha Abdullah MohammedAmeen, Mohammed Omer Mohammed, Rebaz HamaGareb Ali, Khadija Muhamed Ahmed, Saad Abdulrahman Hussain
Format: Article
Language:English
Published: College of Pharmacy / Mustansiriyah University 2019-12-01
Series:Al-Mustansiriyah Journal of Pharmaceutical Sciences
Subjects:
Online Access:https://ajps.uomustansiriyah.edu.iq/index.php/AJPS/article/view/625
_version_ 1797223915933663232
author Hazha Abdullah MohammedAmeen
Mohammed Omer Mohammed
Rebaz HamaGareb Ali
Khadija Muhamed Ahmed
Saad Abdulrahman Hussain
author_facet Hazha Abdullah MohammedAmeen
Mohammed Omer Mohammed
Rebaz HamaGareb Ali
Khadija Muhamed Ahmed
Saad Abdulrahman Hussain
author_sort Hazha Abdullah MohammedAmeen
collection DOAJ
description Oral mucositis (OM) is common treatment-induced toxicity in patients receiving chemoradiation for head and neck cancer (HNC). The present study aims to evaluate the efficacy and safety of Nigella sativa (NS) oil in chemoradiation-induced OM of HNC patients. From   January 2017 to May 2018, 40 patients with HNC were randomly allocated into two groups each of 20 patients. The first group received NS oil mouthwash five times daily, while the second group received the routinely followed protocol (magic mouthwash) and served as a control. All patients received radiotherapy (RT) (60-70 Gy) in 30-35 fractions over 6-7 weeks with or without chemotherapy. Patients were evaluated weekly to estimate the onset and severity of OM and the patient’s reported outcomes (pain, swallowing, and functional score). The majority of patients (70%) were men. The commonest primary tumor locations were the larynx (47.5), and pharynx (22.5%) mostly classified as stages III or IV. NS oil significantly reduces the RTOG of mucositis in the last 3 weeks of RT and improves the reported outcomes (pain and swallowing) during the next 6 weeks of RT compared with controls. The majority of patients in the NS group ingested either normal or soft food especially at the end of RT. In conclusion, NS oil decreases the duration and severity of OM with better patient-reported outcome and pain control compared with the routine treatment. NS oil can be considered as a feasible and affordable option for chemoradiation-induced OM in HNC patients.
first_indexed 2024-04-24T13:44:49Z
format Article
id doaj.art-4772914141c64729ac77ff3ff3ecc190
institution Directory Open Access Journal
issn 1815-0993
2959-183X
language English
last_indexed 2024-04-24T13:44:49Z
publishDate 2019-12-01
publisher College of Pharmacy / Mustansiriyah University
record_format Article
series Al-Mustansiriyah Journal of Pharmaceutical Sciences
spelling doaj.art-4772914141c64729ac77ff3ff3ecc1902024-04-04T06:57:54ZengCollege of Pharmacy / Mustansiriyah UniversityAl-Mustansiriyah Journal of Pharmaceutical Sciences1815-09932959-183X2019-12-0119310.32947/ajps.v19i3.625Nigella Sativa Oil for Oral MucositisHazha Abdullah MohammedAmeen0Mohammed Omer Mohammed1Rebaz HamaGareb Ali2Khadija Muhamed Ahmed3Saad Abdulrahman Hussain4Department of Medicine, College of Medicine, University of Sulaimani. Kurdistan Region, IraqDepartment of Medicine, College of Medicine, University of Sulaimani. Kurdistan Region, IraqDepartment of Pharmaceutics, College of Pharmacy, University of Sulaimani, Kurdistan Region, IraqDepartment of Oral Pathology, College of Dentistry, University of Sulaimani, Kurdistan Region, IraqDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Al-Rafidain University College, Baghdad, Iraq Oral mucositis (OM) is common treatment-induced toxicity in patients receiving chemoradiation for head and neck cancer (HNC). The present study aims to evaluate the efficacy and safety of Nigella sativa (NS) oil in chemoradiation-induced OM of HNC patients. From   January 2017 to May 2018, 40 patients with HNC were randomly allocated into two groups each of 20 patients. The first group received NS oil mouthwash five times daily, while the second group received the routinely followed protocol (magic mouthwash) and served as a control. All patients received radiotherapy (RT) (60-70 Gy) in 30-35 fractions over 6-7 weeks with or without chemotherapy. Patients were evaluated weekly to estimate the onset and severity of OM and the patient’s reported outcomes (pain, swallowing, and functional score). The majority of patients (70%) were men. The commonest primary tumor locations were the larynx (47.5), and pharynx (22.5%) mostly classified as stages III or IV. NS oil significantly reduces the RTOG of mucositis in the last 3 weeks of RT and improves the reported outcomes (pain and swallowing) during the next 6 weeks of RT compared with controls. The majority of patients in the NS group ingested either normal or soft food especially at the end of RT. In conclusion, NS oil decreases the duration and severity of OM with better patient-reported outcome and pain control compared with the routine treatment. NS oil can be considered as a feasible and affordable option for chemoradiation-induced OM in HNC patients. https://ajps.uomustansiriyah.edu.iq/index.php/AJPS/article/view/625Nigella sativa; oral mucositis; chemoradiation; head and neck cancer
spellingShingle Hazha Abdullah MohammedAmeen
Mohammed Omer Mohammed
Rebaz HamaGareb Ali
Khadija Muhamed Ahmed
Saad Abdulrahman Hussain
Nigella Sativa Oil for Oral Mucositis
Al-Mustansiriyah Journal of Pharmaceutical Sciences
Nigella sativa; oral mucositis; chemoradiation; head and neck cancer
title Nigella Sativa Oil for Oral Mucositis
title_full Nigella Sativa Oil for Oral Mucositis
title_fullStr Nigella Sativa Oil for Oral Mucositis
title_full_unstemmed Nigella Sativa Oil for Oral Mucositis
title_short Nigella Sativa Oil for Oral Mucositis
title_sort nigella sativa oil for oral mucositis
topic Nigella sativa; oral mucositis; chemoradiation; head and neck cancer
url https://ajps.uomustansiriyah.edu.iq/index.php/AJPS/article/view/625
work_keys_str_mv AT hazhaabdullahmohammedameen nigellasativaoilfororalmucositis
AT mohammedomermohammed nigellasativaoilfororalmucositis
AT rebazhamagarebali nigellasativaoilfororalmucositis
AT khadijamuhamedahmed nigellasativaoilfororalmucositis
AT saadabdulrahmanhussain nigellasativaoilfororalmucositis